Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome

Article English OPEN
Enzo Vicari ; Michele Salemi ; Giuseppe Sidoti ; Mariano Malaguarnera ; Roberto Castiglione (2017)
  • Publisher: MDPI AG
  • Journal: Nutrients, volume 9, issue 11 (issn: 2072-6643, eissn: 2072-6643)
  • Related identifiers: pmc: PMC5707680, doi: 10.3390/nu9111208
  • Subject: Nutrition. Foods and food supply | chronic pelvic pain syndrome | TX341-641 | irritable bowel syndrome | rifaximin | probiotic VSL#3 | Article | irritable bowel syndrome-severity scoring system

This study investigated the effects of long-term treatment with rifaximin and the probiotic VSL#3 on uro-genital and gastrointestinal symptoms in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) plus diarrhoea-predominant irritable bowel syndrome... View more
Share - Bookmark